Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725534 | SCV000337585 | uncertain significance | not provided | 2016-09-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086719 | SCV000555116 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725534 | SCV000727189 | likely benign | not provided | 2019-08-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000725534 | SCV002063937 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |
Ambry Genetics | RCV002365297 | SCV002658560 | likely benign | Cardiovascular phenotype | 2020-11-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000725534 | SCV003823617 | likely benign | not provided | 2023-08-28 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000725534 | SCV001742949 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000363959 | SCV001917853 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000725534 | SCV001957144 | likely benign | not provided | no assertion criteria provided | clinical testing |